PerkinElmer, Inc. is a provider of technology, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. Through the Company's advanced technologies, solutions, and services, it addresses issues related to health and safety of people and their environment. It operates in two segments: Human Health and Environmental Health. In February 2011, it acquired chemagen Biopolymer-Technologie AG (chemagen). In March 2011, it acquired ArtusLabs, Inc. (ArtusLabs). In March 2011, it acquired specified assets and assumed specified liabilities of ID Biological Systems, Inc. (IDB). In April 2011, it acquired CambridgeSoft Corporation (CambridgeSoft). In May 2011, it acquired Geospiza, Inc. (Geospiza). In May 2011, it acquired Labtronics, Inc. (Labtronics). In June 2011, it acquired Dexela Limited (Dexela). In November 2011, it acquired Caliper Life Sciences, Inc. (Caliper).
|Headquarters||940 Winter Street|
WALTHAM, MA, United States 02451
|Chairman of the Board, President, Chief Executive Officer||Robert Friel|
|Chief Financial Officer, Senior Vice President||Frank Wilson|
|Chief Scientific Officer, Senior Vice President, President - Emerging Diagnostics||Daniel Marshak|
|Senior Vice President, General Counsel, Secretary||Joel Goldberg|
|Senior Vice President - Human Resources||John Letcher|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
|Shares Out.||111.9M||Book Value||$16.86|
|Annual Dividend Rate||$0.28||Price/Sales (TTM)||1.8|
|Ex-Div Date||4/17/13||P/Cash Flow (TTM)||13.1x|
|Pay Date||8/9/13||Operating Margin||4.65%|
*GAAP = prior to non-GAAP analyst adjusted earnings.